Policy
HAI produces critical scholarship on AI governance and convenes national and global AI discussions. We engage with leaders and policymakers worldwide to ensure AI is designed to augment human capabilities and benefit society.
Recently Published in Policy Publications
Response to FDA's Request for Comment on AI-Enabled Medical Devices
Stanford scholars respond to a federal RFC on evaluating AI-enabled medical devices, recommending policy interventions to help mitigate the harms of AI-powered chatbots used as therapists.
Stanford scholars respond to a federal RFC on evaluating AI-enabled medical devices, recommending policy interventions to help mitigate the harms of AI-powered chatbots used as therapists.
Moving Beyond the Term "Global South" in AI Ethics and Policy
This brief examines the limitations of the term "Global South" in AI ethics and policy, and highlights the importance of grounding such work in specific regions and power structures.
This brief examines the limitations of the term "Global South" in AI ethics and policy, and highlights the importance of grounding such work in specific regions and power structures.
Jen King's Testimony Before the U.S. House Committee on Energy and Commerce Oversight and Investigations Subcommittee
In this testimony presented to the U.S. House Committee on Energy and Commerce’s Subcommittee on Oversights and Investigations hearing titled “Innovation with Integrity: Examining the Risks and Benefits of AI Chatbots,” Jen King shares insights on data privacy concerns connected with the use of chatbots. She highlights opportunities for congressional action to protect chatbot users from related harms.
In this testimony presented to the U.S. House Committee on Energy and Commerce’s Subcommittee on Oversights and Investigations hearing titled “Innovation with Integrity: Examining the Risks and Benefits of AI Chatbots,” Jen King shares insights on data privacy concerns connected with the use of chatbots. She highlights opportunities for congressional action to protect chatbot users from related harms.
Russ Altman’s Testimony Before the U.S. Senate Committee on Health, Education, Labor, and Pensions
In this testimony presented to the U.S. Senate Committee on Health, Education, Labor, and Pensions hearing titled “AI’s Potential to Support Patients, Workers, Children, and Families,” Russ Altman highlights opportunities for congressional support to make AI applications for patient care and drug discovery stronger, safer, and human-centered.
In this testimony presented to the U.S. Senate Committee on Health, Education, Labor, and Pensions hearing titled “AI’s Potential to Support Patients, Workers, Children, and Families,” Russ Altman highlights opportunities for congressional support to make AI applications for patient care and drug discovery stronger, safer, and human-centered.
